
Article
AI is decoding microbial patterns humans can't see. Here's how machine learning is transforming microbiome research into clinical ...
AI is decoding microbial patterns humans can't see. Here's how machine learning is transforming microbiome research into clinical reality.

ML virtual screening hits 18-45% in prospective trials vs sub-1% for HTS, unlocking undruggable cancer targets.

Physics vs generative AI for cancer drug design. Schrodinger and Insilico Medicine compared pipeline, deals, and proof.

Fewer than 700 of 20,000 human proteins have ever yielded a drug. 5 AI platforms are unlocking oncology's "undruggable" targets.

AI drug discovery raised billions in deals. Deloitte's 2026 report found the ROI "hasn't been realized at scale" yet. Here's why.
